Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-15

Clinical Trial Update: Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy [NA]

View source ↗

Summary

This entry notes a planned clinical trial evaluating the TENEO 317 Model 2 Excimer Laser for transepithelial photorefractive keratectomy to treat myopia with or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Myopia | NA | Status: NOT_YET_RECRUITING